This fits well with reports that in a variety of tumors, high serum IL-6 levels correlate with a less favorable prognosis, including MM27, head and neck cancer28, non-small cell lung cancer29, colorectal carcinoma, and ovarian carcinoma30. This evidence concerns the gene IL6 and colorectal carcinoma.